Rethink patient recruitment
Discover a new way to engage hard-to-reach patients for traditional and decentralized clinical trials.
Engage research-ready patient populations
Discover new patient insights
Get ahead with patient-powered studies
Finding patients is hard. Finding rare patients is even harder
Driven by a deep and personal insight into life with a rare disease, as well as an innate understanding of digital technology and web behavior, we have developed a proven methodology for finding and engaging hard-to-reach patients.
Tailored digital campaigns
When it comes to reaching rare patients, no two scenarios are the same. That’s why we tailor recruitment strategies to specific indications and study requirements.
Our highly experienced digital marketing specialists have developed unique techniques for finding and engaging niche patient populations, through our in-depth understanding of search engines, social media platforms, and online patient behavior.
Armed with data, knowledge, and empathy, we create holistic digital experiences that reach patients previously thought unreachable.
Early audience insights
Finding patients to take part in rare disease clinical and real-world studies can be incredibly challenging.
Our Early Audience Insights programs involve extensive research and analysis to understand the digital behavior of targeted patient populations and assess reachability and likelihood of engagement.
Real-time dashboards provide unique insights that inform protocol feasibility and recruitment strategies, strengthening the chance of study success.
Engage research-ready patients
We build relationships with patients and caregivers from the beginning, running trial education programs where appropriate and giving patients value through Raremark.
This helps patients and caregivers understand the importance of research, particularly for rare disease, what taking part would mean, and how it might benefit them.
When patients are ready to participate in research, we connect them to relevant study opportunities using our specialized matching engine.
Decentralized Trials
Clinical trials are changing, the move towards decentralized trials is bringing a more patient-focused approach to clinical research.
This is especially valuable for rare disease patients, where the burden of travel and site visits can be a significant barrier to study participation.
Provide rare disease patients the opportunity to participate in trials regardless of where they live:
- Assess study feasibility based on patient location
- Refine study design based on patient requirements.
- Match the right patients to the right studies
